SSTR4 and Alzheimer disease: Nevertheless, the current observations in conjunction with other work identifying anti-inflammatory capacity [29, 35, 36], cognitive enhancement [7–9], and the ability to decrease cortical Aβ oligomer expression [7, 8] supports further investigation of SSTR4 agonists for AD treatment.